Variation in serum level of IL-2 and IL-8 in lung fibrosis

Archives of Medical Science

Volumn 4, Issue 1, 2008, Pages 26-31

  Ezzeldin, Nada ^a   Saad, Nevine E ^a   Ezzeldin, Howayda ^a   Mohsen, Mona ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Cytokines; Interleukin; Pulmonary fibrosis; T helper

Indexed keywords

CYCLOPHOSPHAMIDE; INTERLEUKIN 2; INTERLEUKIN 8; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; LUNG FIBROSIS; LUNG TUBERCULOSIS; PATHOGENESIS; PNEUMONIA; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

EID: 42549171537     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Scadding JG. Diffuse pulmonary alveolar fibrosis. Thorax 1974; 29: 271-81.
2. Bitterman PB, Adelberg S, Crystal RG. Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. J Clin Invest 1983; 72: 1801-13.
3. Kallenberg CG, Schilizzi BM, Beaumont E, et al. Expression of cell II major histocompatibility complex antigen on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis. J Clin Pathol 1987; 40: 725-33.
4. Patchefsky AS, Banner M, Freundlich IM. Desquamative interstitial pneumonia. Significance of intranuclear viral-like inclusion bodies. Ann Intern Med 1971; 74: 322-7.
5. Bitterman PB, Rennard SI, Keogh BA, Wewers MD, Adelberg S, Crystal RG. Familial idiopathic pulmonary fibrosis: evidence of lung inflammation in unaffected family members. N Engl J Med 1986; 314: 1343-7.
6. Rom WN, Travis WD, Brody AR. Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis 1991; 143: 408-22.
7. Lukacs NW, Hogaboam C, Chensue SW, Blease K, Kunkel SL. Type 1/type 2 cytokine paradigm and the progression of pulmonary fibrosis. Chest 2001; 120: 5S-8S.
8. Infante-Duarte C, Kamradt T. Th1/Th2 balance in infection. Springer Semin Immunopathol 1999; 21: 317-38.
9. Biedermann T, Röcken M. Th1/Th2 balance in atopy. Springer Semin Immunopathol 1999; 21: 295-316.
10. Shurin MR, Lu L, Kalinski P, Stewart-Akers AM, Lotze MT. Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 1999; 21: 339-59.
11. Strieter RM. Mechanisms of pulmonary fibrosis: Conference summary. Chest 2001; 20: S77-S85.
12. Chensue SW, Otterness IG, Higashi GI. Monokine production by hypersensitivity (Schistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages. Evidence for sequential production of IL-1 and TNF. J Immunol 1989; 142: 1281-6.
13. Sibille Y, Houssiau F, Pochet JM, et al. Macroglobulin and interleukin-6 release by human alveolar macrophages from normal and sarcoidosis patients. Am Rev Respir Dis 1990; 141: A8712.
14. Lynch JP 3rd, Standiford TJ, Rolfe MW. Neutrophilic alveolitis in idiopathic pulmonary fibrosis: the role of interleukin-8. Am Rev Respir Dis 1992; 145: 1433-9.
15. Standiford TJ, Rolfe MW, Kunkel S, et al. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease. J Immunol 1993; 151: 2852-63.
16. Chensue SW, Warmington KS, Lukacs NW, et al. Monocyte chemotactic protein (MCP-1) expression during schistosome egg granuloma formation. Sequence of production, localization, contribution, and regulation. Am J Pathol 1995; 146: 130-8.
17. Bachwich PR, Lynch JP 3rd, Larrick J, Spengler M, Kunkel SL. Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol 1986; 125: 421-5.
18. Khalil N, Bereznay O, Sporn M, Greenberg AH. Macrophage production of transforming growth factor-beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989; 170: 727-37.
19. Gauldie J, Jordana M, Cox G. Cytokines and pulmonary fibrosis. Thorax 1993; 48: 931-5.
20. Bonner JC, Osornio-Vargas AR, Badgett A, Brody AR. Differential proliferation of rat lung fibroblasts induced by the platelet-derived growth factor-AA, AB, and BB isoforms secreted by alveolar macrophages. Am J Respir Cell Mol Biol 1991; 5: 539-47.
21. Strieter RM, Keane MP. Cytokine biology and the pathogenesis of interstitial lung disease. In: New Approaches to Managing Idiopathic Pulmonary Fibrosis. King TE Jr ed. New York, NY: American Thoracic Society 2000; 27-35.
22. Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin-4. J Clin Invest 1992; 90: 1479-85.
23. Wallace WA, Ramage EA, Lamb D, Howie SE. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 1995; 101: 436-41.
24. Mefferd JM, Donaldson SS, Link MP. Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys 1989; 16: 679-85.
25. Marina NM, Greenwald CA, Fairclough DL, et al. Serial pulmonary function studies in children treated for newly diagnosed Hodgkin's disease with mantle radiotherapy plus cycles of cyclophosphamide, vincristine, and procarbazine alternating with cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine. Cancer 1995; 75: 1706-11.
26. Keane MP, Belperio JA, Burdick MD, Strieter RM. IL-12 attenuates bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2001; 281: L92-7.
27. Hein R, Behr J, Hündgen M, et al. Treatment of systemic sclerosis with gamma-interferon. Br J Dermatol 1992; 126: 496-501.
28. Keane MP, Strieter RM. The importance of balanced proinflammatory and anti-inflammatory mechanisms in diffuse lung disease. Respir Res 2002; 3: 5.